409A Valuation in Irvine and Orange County

How this page fits with our other guides: California's state-level rules, including its 5% additional tax on 409A failures, its treatment of ISOs and Section 25102(o) option plan filings, apply to every Orange County company and are covered in our 409A valuation guide for California startups. The FDA pathway and reimbursement mechanics behind any device valuation are covered in our 409A guide for healthcare and medtech companies. This page covers only what is specific to Irvine and Orange County. For the basics, start with what is a 409A valuation.

Does an Irvine startup need a 409A valuation?

Yes, if it grants stock options, stock appreciation rights or similar equity to employees, advisors or contractors. Section 409A is federal, so the rule in Irvine is the same as everywhere else: the exercise price must be at least the fair market value of the stock on the grant date. A 409A valuation is how a private company supports that value.

The valuation earns a presumption of reasonableness if it is prepared by a qualified, independent appraiser, is no more than 12 months old, and no material event has happened since. With that presumption in place, the IRS has to show the value was grossly unreasonable before it can challenge it. Our 409A safe harbor guide explains the three routes to that presumption. Without it, an option priced below fair market value can become deferred compensation that fails Section 409A, and the employee, not the company, owes the income tax on vested amounts, a 20% additional federal tax and interest, plus California's own 5% additional tax.

The question comes up in Orange County earlier than founders expect. Spinouts from large device makers often hire senior engineers and clinical staff before they raise outside money, and they promise equity to do it. The first grant needs a valuation behind it, even if the company has only a prototype and a handful of employees.

The Orange County economy behind a 409A valuation

Industry decides which valuation approach carries the most weight and which public companies are fair comparables, so an Orange County 409A valuation starts there. The county's mix is distinct from both Los Angeles and San Diego:

• Medical devices. Irvine and the surrounding cities host the headquarters of Edwards Lifesciences and Masimo in Irvine, Glaukos in Aliso Viejo and Applied Medical in Rancho Santa Margarita, along with Medtronic's neurovascular business in Irvine. Decades of cardiovascular, ophthalmic, neurovascular and surgical device work have produced a deep bench of engineers, regulatory specialists and repeat founders.
• Defense tech and advanced hardware. Anduril Industries is based in Costa Mesa, and a wider set of aerospace, autonomy, sensor and manufacturing companies operates across the county.
• Automotive and electric vehicles. Rivian is headquartered in Irvine, and Kia America and Mazda North American Operations are also based there. Suppliers, charging companies and vehicle-software startups follow them.
• Fintech and real estate finance. Irvine and its neighbors are a center for nonbank mortgage lenders and real estate finance. Startups build lending software, servicing tools and property-data products for that industry.
• Consumer brands and gaming. Costa Mesa and Huntington Beach are long-standing bases for surf, skate and action-sports apparel, and Blizzard Entertainment is based in Irvine.
• University and cybersecurity. UC Irvine's Beall Applied Innovation runs the campus's licensing and its Wayfinder incubator, and the county has a cybersecurity history that includes Cylance, the Irvine company acquired by BlackBerry.

The common thread is that many Orange County startups are built to be bought. A device company may be designed from day one around the product gap of a specific large acquirer, and a hardware startup may aim to become a supplier and then a target. That shapes the exit scenarios in an Irvine 409A valuation more than any single financial input.

Orange County company types and their 409A valuation drivers

The table below summarizes how the main Orange County company types are typically valued for 409A purposes. These are general patterns, not rules; every valuation depends on the company's stage, financing history and capital structure.

Two Orange County patterns recur. Mortgage-technology revenue rises and falls with interest rates and refinancing volume, so a 409A valuation struck in a busy refinancing year should not treat that year as the run rate. And profitable founder-owned companies often have no exit planned at all, which makes the discount for lack of marketability a larger part of the answer. Our comparison of DLOM models explains how that discount is measured.

Strategic-acquirer exits and earnouts in an Orange County 409A

Most venture-backed medical device companies are sold rather than listed, and Orange County's cluster makes the pattern especially strong. That matters because the allocation of value between preferred and common stock depends on how and when the company is expected to exit.

When exit paths are reasonably clear, appraisers often use the probability-weighted expected return method (PWERM), or a hybrid OPM-PWERM approach when the company also has a recent priced round. A typical device company might be modeled with scenarios such as a sale after FDA clearance, a later sale after commercial traction, a sale at a lower value after a setback, and a dissolution. Each scenario has a probability, a value and a timing, and the common stock is valued within each one.

Medtech acquisitions are often paid partly up front and partly through earnouts tied to regulatory approval or sales targets. A careful valuation does not treat the full headline price as the exit value. It risk-adjusts and discounts each contingent payment, and then runs those amounts through the liquidation preferences. Because preferred stock is paid first, earnout risk often falls more heavily on the common stock than on investors. If a company has received an acquisition approach or signed a letter of intent, that is usually a material event and the scenario weights should be revisited before new grants.

Founders leaving a large employer: IP ownership and value

A large share of Orange County device and hardware startups are founded by people who left one of the county's established companies. For the 409A appraiser, that raises a question that rarely appears in a software valuation: does the company clearly own its core technology?

California Labor Code Section 2870 limits what an employer can require an employee to assign. An invention developed entirely on the employee's own time, without the employer's equipment, supplies, facilities or trade secrets, generally cannot be claimed. That protection does not apply when the invention relates to the employer's business or its actual or demonstrably anticipated research, or results from work the employee did for the employer. A cardiac device engineer who designs a new valve delivery system on weekends may therefore still face a claim from a former employer in the same field.

An appraiser cannot resolve that legal question, but they have to account for it. If counsel has confirmed clean title, the projections can be relied on as presented. If there is an open dispute or an unreleased claim, the risk usually shows up as a lower probability of success, a higher discount rate or an explicit litigation scenario. Founders should have their IP position reviewed before the first valuation, not after a buyer's diligence team raises it. California's general bar on employee noncompete agreements does not remove these assignment and trade-secret obligations.

UC Irvine spinouts and university license terms

Companies formed around technology licensed from UC Irvine, or from other University of California campuses, bring a license agreement into the valuation. Those agreements commonly include some combination of an upfront fee, annual minimums, royalties on sales, milestone payments, a share of sublicense income and, in some cases, an equity stake for the university.

Each term affects value differently. Royalties and milestone payments reduce the cash flows that belong to shareholders, so they belong in any projection or acquirer-value estimate. A share of sublicense income reduces what the company keeps if it licenses the technology onward. The university's shares are counted in the capital structure, and any anti-dilution protection on them changes how later financings dilute the common stock. Diligence and license-term milestones can also be value events: losing exclusivity in a field of use is as material as a failed test.

Spinouts are often valued before any outside money arrives. At that stage there may be little more than the license, a small team and grant funding, and the cost approach or a carefully supported scenario model is often more defensible than a revenue multiple.

Angel, family office and SAFE financing in Orange County

Orange County has a deep angel investing community, including Tech Coast Angels, one of the country's largest angel networks, and a significant number of family offices in Newport Beach and Irvine. Strategic investors from the medtech and automotive industries also write checks. Large institutional venture funds are fewer than in the Bay Area, so many companies raise their early money on SAFEs or convertible notes rather than priced preferred rounds.

That changes the valuation method. The backsolve method needs a recent, arm's-length price per share. A SAFE with a valuation cap can give the appraiser a reference point, but an uncapped SAFE or a note with only a discount gives much less, and an investment by an insider at a negotiated price may not be arm's length. Without a reliable price, the appraiser relies more on market comparables, scenario models or the cost approach. Our guide to a 409A valuation with SAFE notes explains how outstanding SAFEs are treated in the capital structure.

Strategic investors raise one more issue. A corporate investor may pay a price that reflects commercial benefits to itself, such as a distribution right or a right of first negotiation on an acquisition. Those rights can be valuable to the investor and costly to other shareholders, and the appraiser should consider whether the price paid tells you much about the fair market value of the common stock.

How much does a 409A valuation cost in Irvine?

About the same as anywhere else in the US. A 409A valuation in Irvine is priced on stage and capital structure complexity, not location. Seed-stage reports from online and boutique providers generally cost a few hundred to a few thousand dollars, while companies with several preferred classes, convertible instruments or scenario modeling pay more.

Two Orange County factors push the cost up. Medtech and defense companies usually need scenario models with milestone probabilities and earnout analysis, which take more appraiser time than a simple backsolve. And companies that choose a large Los Angeles or Orange County accounting or advisory firm pay for that firm's overhead. Our 409A valuation cost guide has current price ranges by stage and provider type; we do not repeat those figures here.

Frequency matters as much as price. A device company working toward clearance, a first sale and a Series A may need two or three valuations in a year, because each milestone can reset the value. Budget for the refreshes, not just the first report.

Do you need an Orange County 409A valuation firm?

No. California does not license business appraisers, and the 409A safe harbor depends on the appraiser's qualifications, experience and independence, not on where they work. A remote provider that applies federal rules and AICPA guidance produces a report that is equally valid for an Orange County company. Industry experience matters far more than a local office.

The better questions are specific. Has the appraiser valued medical device, defense or hardware companies before? How do they model strategic-acquirer exits and earnouts? How do they treat university license terms and SAFEs without caps? Who signs the report, and what credentials do they hold, such as ASA, ABV, CFA or CVA? Our guide to online 409A valuations vs traditional firms compares the two delivery models, and our step-by-step guide on how to get a 409A valuation lists the documents to gather before you start.

Independence is worth checking in a tight local market. An appraiser who also advises the company's likely acquirer, or a firm that audits the company, may face conflicts that weaken the safe harbor or create audit problems later.

Preparing for an Orange County 409A valuation

Beyond the standard package of financial statements, cap table, financing documents and projections, Orange County companies can save time by having these ready:

• Device companies: the regulatory plan and timeline, clinical study status, any acquirer conversations or term sheets, and the milestone schedule behind the next financing.
• Founders from a large employer: the IP assignment agreements, any releases from the former employer and counsel's view on title to the core technology.
• University spinouts: the full license agreement, including royalty, milestone, sublicense, diligence and equity terms.
• Defense and hardware companies: contract awards with funded and unfunded amounts, production plans and capital requirements.
• SAFE-funded companies: every SAFE and note with its cap, discount and conversion terms, and details of any strategic investor rights.

Our overview of the 409A valuation process walks through what happens after you hand those documents over, from kickoff to the board-approved report. Founders elsewhere in the state can see how other regions differ in our guides to the California 409A landscape and to Bakersfield and Kern County.

The Bottom Line on an Irvine 409A Valuation

An Irvine 409A valuation is the same federal report every US company needs before it grants options, built to the same standard and subject to the same California rules as a company in the Bay Area. What sets Orange County apart is the work behind the numbers: modeling strategic-acquirer exits and earnouts for medtech companies, accounting for IP ownership when founders leave a large employer, reflecting university license terms for UC Irvine spinouts, and finding a defensible value when angel and family-office SAFEs leave no recent priced round.

The routine does not change. Get an independent Orange County 409A valuation before the first grant, refresh it at least every 12 months and after each material event, pause grants when an acquisition approach arrives, and choose an appraiser for industry experience rather than a local address. Companies that keep that discipline give their teams equity they can rely on and give acquirers nothing to unwind in diligence.

This article is general information about 409A valuations for Irvine and Orange County companies, not legal, tax or accounting advice. Federal and California tax rules change, and their application depends on each company's and employee's facts. Questions about IP ownership, university licenses and equity plan documents should be reviewed by counsel. Consult your own legal and tax advisors before granting equity or exercising options.